1Hirai T,Sasayama S,Kawasaki T,et al.Stiffness of systemic arteries in patients with myocardial infarction:a noninvasive method to predict severity of coronary atherosclerosis[J].Circulation,1989,80(1):78-85.
2Bonora E,Tessari R,Micciolo R,et al.Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients:relationship with insulin resistance[J].Diabetes Care,1997,20(4):627-631.
6Emoto M,Nishizawa Y,Kawagisi T,et al.Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM[J].Diabetes Care,1998,21(7):1178-1182.
8Salomaa AR,Riley W,Kark JD,et al.Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentration are associated with arterial stiffness indexs:ARIC study[J].Circulation,1995,91(5):1432-1443.
10Steinberg HO,Chaker H,Leaming R,et al.Obesity/insulin resistance is associated with endothelial dysfunction:implications for the syndrome of insulin resistance[J].J Clin Invest,1996,97(11):2601-2610.
2Barzilay Jl;Abraham L; Heckbert SR,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes,2001,50:2384-2349.
3Salonen JT, Salonen R. Ultrasound B-mode in observational studies of atherosclerotic progress. Circulation, 1993,87 (3 Suppl) : IL56-65.
4Haffner SM, Mykkanen L, Festa A, et al. Insulin-reslstant prediabetic subjects have more atherogenlc risk factors than insulin-sensitive prediabetic subjects. Circulation,2000,101:975-980.
5Festa A, D' Agostlno R, Howard G, et al. Chronic sub-clinlcal inflammation as part of the insulin-resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation,2000,102:42-47.
6Espeland MA, Hoen H, Byington R, Howard G, Riley WA, Furberg CD, et al. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography. Stroke, 1994, 25 (9) : 1 812-819.
7Bretzel RG, Voigt K, Schatz H. The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes, 1998, 106 (4): 369-372.
8Haffner SM. Epdemiology of insulin resistance and its relation to coronary artery disease. American J Cardiology, 1999, 84 (1A) : 11J-14J.
9Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD, et al. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes, 1994, 43 (2): 204-211.
10Jiang C, Ting A, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature, 1998, 391 (6662): 82-86.
